Bruush Oral Care Inc. (NASDAQ: BRSH) stock fell -12.10% on Monday to $0.35 against a previous-day closing price of $0.40. With 2.25 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $0.4510 whereas the lowest price it dropped to was $0.3236. The 52-week range on BRSH shows that it touched its highest point at $3.88 and its lowest point at $0.38 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BRSH was down-trending over the past week, with a drop of -36.07%, but this was down by -26.75% over a month.
Float and Shares Shorts:
At present, 8.15 million BRSH shares are outstanding with a float of 6.76 million shares on hand for trading. On Oct 13, 2022, short shares totaled 40030.0, which was 0.55% higher than short shares on Sep 14, 2022. In addition to Mr. Aneil Singh Manhas as the firm’s Founder, Pres, CEO & Chairman, Mr. Matthew Kavanagh serves as its Chief Financial Officer.
Through their ownership of 8.69% of BRSH’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of BRSH, in contrast to — held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in BRSH with 0.58% of the stake, Jane Street Capital LLC holds 42,814 shares worth 42,814. A second-largest stockholder of BRSH, Citadel Securities LLC, holds 38,326 shares, controlling over 0.52% of the firm’s shares. Virtu Financial BD LLC is the third largest shareholder in BRSH, holding 23,624 shares or 0.32% stake.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BRSH since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BRSH analysts setting a high price target of $5.64 and a low target of $5.64, the average target price over the next 12 months is $5.64. Based on these targets, BRSH could surge 1511.43% to reach the target high and rise by 1511.43% to reach the target low. Reaching the average price target will result in a growth of 1511.43% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.